Top compounds associated with response to CCDC142


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0009
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.0009
mRNA (5Z)-7-Oxozeaenol GDSC1000 pan-cancer AAC -0.1 0.001
mRNA OSI-906 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA MGCD-265 CTRPv2 pan-cancer AAC -0.11 0.001
mRNA Axitinib CTRPv2 pan-cancer AAC -0.11 0.002
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.097 0.002
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
Download CSV